To Join Or Not To Join: The Challenges Of A Joint FDA-Sponsor Adcomm Briefing Document

Point-counterpoint
The point-counterpoint format is currently an option for advisory committee sponsors. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers